[시장보고서]치과용 멤브레인 및 골이식 대체물 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 지역별, 부문별 예측(2025-2033년)

치과용 멤브레인 및 골이식 대체물 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 지역별, 부문별 예측(2025-2033년)

Dental Membrane And Bone Graft Substitutes Market Size, Share & Trends Analysis Report By Product (Bone Graft Substitutes (BGS), Dental Membranes And Soft Tissue Regeneration Materials), By Application, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1842145

리서치사 : Grand View Research

발행일 : 2025년 09월

페이지 정보 : 영문 110 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,810,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,290,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,252,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

치과용 멤브레인 및 골이식 대체물 시장 요약

세계의 치과용 멤브레인 및 골이식 대체물 시장 규모는 2024년에 14억 7,000만 달러로 평가되었으며, 2033년까지 29억 6,000만 달러에 달할 것으로 예측되며, 2025년부터 2033년까지 CAGR은 8.19%로 성장할 것으로 예측됩니다.

치과용 멤브레인 및 골이식 대체물에 대한 수요는 치과 질환의 부담 증가와 심미적, 수복적 치과 시술에 대한 수요 증가로 인해 증가하고 있습니다.

또한, 치과 관광의 증가도 시장 성장을 촉진할 것으로 예상됩니다. 치주질환, 충치, 치아 손실, 구강암을 포함한 치과 질환의 전 세계 유병률 증가는 치과용 멤브레인 및 대체 뼈 이식재 시장의 수요를 크게 견인하고 있습니다. 2025년 3월에 발표된 세계보건기구(WHO) 자료에 따르면, 전 세계적으로 10억 명 이상이 심각한 치주질환을 앓고 있다고 합니다. 또한, 20세 이상 성인의 약 7%, 60세 이상 성인의 약 23%가 완전한 치아 상실을 경험하고 있으며, 종종 임플란트나 뼈 재생 시술을 필요로 합니다. 이러한 통계는 임플란트 및 뼈 재생 시술의 필요성이 증가하고 있음을 입증합니다. 치아의 상실은 턱뼈의 악화로 이어지는 경우가 많은데, 임플란트를 잘 결합시키기 위해서는 골이식재나 골막이 필요하기 때문입니다.

또한, 구강암 발생률의 증가는 치과용 뼈 이식재에 대한 수요를 더욱 증가시킬 것으로 예상됩니다. 구강암의 수술적 치료에서 종양 절제 시 손상되거나 제거된 턱뼈 부위를 재건 및 복원하기 위해 뼈 이식이 자주 필요합니다. 이는 수술의 성공과 수술 후 재활을 촉진하는 데 있어 골이식편이 중요한 역할을 하고 있음을 입증합니다.

또한, 치과 임플란트와 같은 수복 및 심미적 치과 시술에 대한 수요 증가는 치과용 멤브레인 및 대체 뼈 이식재 시장의 성장을 크게 촉진할 것으로 예상됩니다. 임플란트를 단단히 지지할 수 있는 뼈가 부족한 경우 뼈 이식이 필수적입니다. 또한, 치과용 멤브레인은 이식 부위를 보호하고 잇몸 조직이 뼈의 재생을 방해하는 것을 방지하여 치유를 촉진하고 이식 성공률을 높입니다. 치과 임플란트와 같은 시술에 대한 선호도가 계속 증가함에 따라 치과용 멤브레인 및 대체 뼈 이식재와 같은 지지 재료에 대한 수요도 증가하고 있습니다. Twin Dental New York이 2025년 6월에 발표한 조사에 따르면, 미국에서만 연간 약 500만 개의 새로운 치과 임플란트가 식립되고 있습니다. 이처럼 치과 임플란트 치료를 받는 인구가 많아지면서 치과용 멤브레인 및 골이식 대체물에 대한 수요가 증가할 것으로 예상됩니다.

시장 연관 전망
- 상부 시장 전망
시장 역학
- 시장 성장 촉진요인 분석
- 시장 성장 억제요인 분석
- 시장 기회 분석
- 시장 과제 분석
치과용 멤브레인 및 골이식 대체물 시장 : 분석 툴
- 업계 분석 : Porter's Five Forces 분석
- PESTEL 분석

제4장 치과용 멤브레인 및 골이식 대체물 시장 : 제품별 추정·동향 분석

부문 대시보드
세계의 치과용 멤브레인 및 골이식 대체물 시장 제품 변동 분석
세계의 치과용 멤브레인 및 골이식 대체물 시장 규모와 동향 분석(제품별, 2021-2033년)
골이식 대체물(BGS)
치과용 멤브레인 및 연조직 재생 재료

제5장 치과용 멤브레인 및 골이식 대체물 시장 : 용도별 추정·동향 분석

부문 대시보드
세계의 치과용 멤브레인 및 골이식 대체물 시장 용도 변동 분석
세계의 치과용 멤브레인 및 골이식 대체물 시장 규모와 동향 분석(용도별, 2021-2033년)
릿지 증강
사이너스 리프트
치주질환 결손 재생
임플란트 골 재생
소켓 보존
연조직 재생
기타

제6장 치과용 멤브레인 및 골이식 대체물 시장 : 지역 추정·동향 분석

지역 대시보드
시장 규모와 예측 및 동향 분석, 2021-2033년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 인도
- 중국
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제7장 경쟁 구도

주요 시장 진입 기업의 최근 동향과 영향 분석
기업/경쟁 분류
- 이노베이터
벤더 상황
- 주요 판매대리점 및 채널 파트너 리스트
- 주요 고객
- 세계 주요 기업의 시장 점유율 분석(2024년)
- Dentsply Sirona
- Bioteck SpA
- Maxigen Biotech Inc.
- Institut Straumann AG
- Nobel Biocare Services AG(Envista)
- Geistlich Holding
- ZimVie Inc.
- NovaBone(Halma)
- Osteogenics Biomedical(Envista)
- Regenity
- Medtronic
- BioHorizons
- REGEDENT AG
- IDL Dental Technologies LTD
- EUCARE PHARMACEUTICALS(P) LTD
- Curasan, Inc.
- TBR Dental
- DentiumUSA
- Tecnoss Dental Srl(Tecnoss srl)
- Unicare Biomedical, Inc.
- Neoss
- Advanced Medical Solutions Group plc
- B&B Dental Implant Company
- Botiss
- Septodont Holding
- Implant Direct Corporation(Envista)
- META BIOMED CO,. LTD
- SigmaGraft Biomaterials
히트맵 분석/기업 시장 상황 분석
기업별 시장 점유율 예측·분석(2024년)
기타 주요 시장 진입 기업 리스트

KSM

영문 목차

영문목차

Dental Membrane And Bone Graft Substitutes Market Summary

The global dental membrane and bone graft substitutes market size was valued at USD 1.47 billion in 2024 and is projected to reach USD 2.96 billion by 2033, growing at a CAGR of 8.19% from 2025 to 2033. The demand for dental membranes and bone graft substitutes is rising owing to the increasing burden of dental disorders and the growing demand for aesthetic and restorative dental procedures.

In addition, increasing dental tourism is also expected to propel market growth. The rising global prevalence of dental disorders, including periodontal disease, tooth decay, tooth loss, and oral cancer, significantly drives demand in the dental membrane and bone graft substitutes market. According to World Health Organization data published in March 2025, more than 1 billion people suffer from severe periodontal disease worldwide. Additionally, about 7% of adults aged 20 and above and around 23% of those over 60 experience complete tooth loss, often requiring implants and bone regeneration procedures. These statistics underscore the growing necessity for dental implants and bone regeneration procedures, as tooth loss frequently leads to jawbone deterioration, requiring bone graft substitutes and membranes to support successful implant integration.

Moreover, the increasing incidence of oral cancer is anticipated to boost the demand for dental bone grafts further. During surgical treatment for oral cancer, bone grafts are frequently required to reconstruct and restore areas of the jawbone that have been damaged or removed during tumor excision. This underscores the vital role that bone graft substitutes play in facilitating successful surgical outcomes and post-operative rehabilitation.

Furthermore, the rising demand for restorative and aesthetic dental procedures like dental implantation is anticipated to significantly drive the growth of the dental membrane and bone graft substitutes market. When bone is insufficient to support an implant securely, bone grafting becomes essential. In addition, a dental membrane protects the graft site and prevents gum tissue from disrupting bone regeneration, thereby enhancing healing and improving graft success rates. As the preference for procedures like dental implantation continues to grow, so does the demand for supportive materials such as dental membranes and bone graft substitutes. According to a study published by Twin Dental New York in June 2025, about 5 million new dental implants are placed yearly in the U.S. alone. Thus, the significant population undergoing dental implantation is anticipated to drive the demand for dental membranes and bone graft substitutes.

Global Dental Membrane And Bone Graft Substitutes Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global dental membrane and bone graft substitutes market report based on product, application, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Bone Graft Substitutes (BGS)
- Allograft
- Demineralized Bone Matrix
- Others
- Autograft
- Xenograft
- Bovine Derived
- Porcine Derived
- Others
- Synthetic
- Hydroxyapatite (HA)
- Tricalcium Phosphate (TCP)
- Bioactive Glass
- Others
Dental Membranes and Soft Tissue Regeneration Materials
- Resorbable Membranes
- Bovine -derived collagen based
- Porcine derived collagen based
- Others
- Non- Resorbable Membrane
- Expanded PTFE (ePTFE)
- Dense PTFE (dPTFE)
- Titanium-Reinforced PTFE
Application Outlook (Revenue, USD Million, 2021 - 2033)
Ridge Augmentation
Sinus Lift
Periodontal Defect Regeneration
Implant Bone Regeneration
Socket Preservation
Soft Tissue Regeneration
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
  - 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
  - 1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Dental Membrane And Bone Graft Substitutes Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Rising burden of dental disorders
  - 3.2.1.2. Development of synthetic bone grafts
  - 3.2.1.3. Growing demand for aesthetic and restorative dental procedures
  - 3.2.1.4. Increasing dental tourism
- 3.2.2. Market restraint analysis
  - 3.2.2.1. High cost of dental treatments
  - 3.2.2.2. Potential risks and complications associated with dental procedures
- 3.2.3. Market opportunity analysis
  - 3.2.3.1. Increasing number of clinical trials
  - 3.2.3.2. Growing development & approvals of resorbable membranes
  - 3.2.3.3. Expansion into synthetic membrane
  - 3.2.3.4. Strategic partnerships & investment to enhance market presence
  - 3.2.3.5. Expansion opportunities in emerging economies
  - 3.2.3.6. Increasing demand for composite bone grafts
  - 3.2.3.7. Growing focus on 3D printed and custom grafts
- 3.2.4. Market challenge analysis
  - 3.2.4.1. Regulatory and approval complexities
  - 3.2.4.2. Economic and currency exchange risks
3.3. Dental Membrane And Bone Graft Substitutes Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitutes
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political & Legal Landscape
  - 3.3.2.2. Economic and Social Landscape
  - 3.3.2.3. Technological landscape

Chapter 4. Dental Membrane And Bone Graft Substitutes Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Dental Membrane And Bone Graft Substitutes Market Product Movement Analysis
4.3. Global Dental Membrane And Bone Graft Substitutes Market Size & Trend Analysis, by Product 2021 to 2033 (USD Million)
4.4. Bone Graft Substitutes (BGS)
- 4.4.1. Bone graft substitutes (BGS) market estimates and forecasts for 2021 to 2033 (USD Million)
  - 4.4.1.1. Allograft
    - 4.4.1.1.1. Allograft market estimates and forecasts for 2021 to 2033 (USD Million)
      - 4.4.1.1.1.1. Demineralized Bone Matrix
        
        4.4.1.1.1.1.1. Demineralized bone matrix market estimates and forecasts for 2021 to 2033 (USD Million)
      - 4.4.1.1.1.2. Others
        
        4.4.1.1.1.2.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
  - 4.4.1.2. Autograft
    - 4.4.1.2.1. Autograft market estimates and forecasts for 2021 to 2033 (USD Million)
  - 4.4.1.3. Xenograft
    - 4.4.1.3.1. Xenograft market estimates and forecasts for 2021 to 2033 (USD Million)
      - 4.4.1.3.1.1. Bovine Derived
        
        4.4.1.3.1.1.1. Bovine derived market estimates and forecasts for 2021 to 2033 (USD Million)
      - 4.4.1.3.1.2. Porcine Derived
        
        4.4.1.3.1.2.1. Porcine derived market estimates and forecasts for 2021 to 2033 (USD Million)
      - 4.4.1.3.1.3. Others
        
        4.4.1.3.1.3.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
  - 4.4.1.4. Synthetic
    - 4.4.1.4.1. Synthetic market estimates and forecasts for 2021 to 2033 (USD Million)
      - 4.4.1.4.1.1. Hydroxyapatite (HA)
        
        4.4.1.4.1.1.1. Hydroxyapatite (HA) market estimates and forecasts for 2021 to 2033 (USD Million)
      - 4.4.1.4.1.2. Tricalcium Phosphate (TCP)
        
        4.4.1.4.1.2.1. Tricalcium phosphate (TCP) market estimates and forecasts for 2021 to 2033 (USD Million)
      - 4.4.1.4.1.3. Bioactive Glass
        
        4.4.1.4.1.3.1. Bioactive glass market estimates and forecasts for 2021 to 2033 (USD Million)
      - 4.4.1.4.1.4. Others
        
        4.4.1.4.1.4.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
4.5. Dental Membranes and Soft Tissue Regeneration Materials
- 4.5.1. Dental membranes and soft tissue regeneration materials market estimates and forecasts for 2021 to 2033 (USD Million)
  - 4.5.1.1. Resorbable membranes
    - 4.5.1.1.1. Resorbable membranes market estimates and forecasts for 2021 to 2033 (USD Million)
      - 4.5.1.1.1.1. Bovine -derived collagen based
        
        4.5.1.1.1.1.1. Bovine -derived collagen based market estimates and forecasts for 2021 to 2033 (USD Million)
      - 4.5.1.1.1.2. Porcine derived collagen based
        
        4.5.1.1.1.2.1. Porcine derived collagen based market estimates and forecasts for 2021 to 2033 (USD Million)
      - 4.5.1.1.1.3. Others
        
        4.5.1.1.1.3.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
  - 4.5.1.2. Non resorbable membranes
    - 4.5.1.2.1. Non resorbable membranes market estimates and forecasts for 2021 to 2033 (USD Million)
      - 4.5.1.2.1.1. Expanded PTFE (ePTFE)
        
        4.5.1.2.1.1.1. Expanded PTFE (ePTFE) market estimates and forecasts for 2021 to 2033 (USD Million)
      - 4.5.1.2.1.2. Dense PTFE (dPTFE)
        
        4.5.1.2.1.2.1. Dense PTFE (dPTFE) market estimates and forecasts for 2021 to 2033 (USD Million)
      - 4.5.1.2.1.3. Titanium-Reinforced PTFE
        
        4.5.1.2.1.3.1. Titanium-reinforced PTFE market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Dental Membrane And Bone Graft Substitutes Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Dental Membrane And Bone Graft Substitutes Market Application Movement Analysis
5.3. Global Dental Membrane And Bone Graft Substitutes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Ridge Augmentation
- 5.4.1. Ridge augmentation market estimates and forecast 2021 to 2033 (USD Million)
5.5. Sinus Lift
- 5.5.1. Sinus lift market estimates and forecast 2021 to 2033 (USD Million)
5.6. Periodontal Defect Regeneration
- 5.6.1. Periodontal defect regeneration market estimates and forecast 2021 to 2033 (USD Million)
5.7. Implant Bone Regeneration
- 5.7.1. Implant bone regeneration market estimates and forecast 2021 to 2033 (USD Million)
5.8. Socket Preservation
- 5.8.1. Socket preservation market estimates and forecasts for 2021 to 2033 (USD Million)
5.9. Soft Tissue Regeneration
- 5.9.1. Soft tissue regeneration market estimates and forecast 2021 to 2033 (USD Million)
5.10. Others
- 5.10.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Dental Membrane And Bone Graft Substitutes Market: Regional Estimates & Trend Analysis By Product and By Application

6.1. Regional Dashboard
6.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
6.3. North America
- 6.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
- 6.3.2. U.S.
  - 6.3.2.1. Key country dynamics
  - 6.3.2.2. Competitive scenario
  - 6.3.2.3. Regulatory framework
  - 6.3.2.4. Reimbursement scenario
  - 6.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
- 6.3.3. Canada
  - 6.3.3.1. Key country dynamics
  - 6.3.3.2. Competitive scenario
  - 6.3.3.3. Regulatory framework
  - 6.3.3.4. Reimbursement scenario
  - 6.3.3.5. Canada market estimates and forecasts, 2021 - 2033
- 6.3.4. Mexico
  - 6.3.4.1. Key country dynamics
  - 6.3.4.2. Competitive scenario
  - 6.3.4.3. Regulatory framework
  - 6.3.4.4. Reimbursement scenario
  - 6.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
6.4. Europe
- 6.4.1. UK
  - 6.4.1.1. Key country dynamics
  - 6.4.1.2. Competitive scenario
  - 6.4.1.3. Regulatory framework
  - 6.4.1.4. Reimbursement scenario
  - 6.4.1.5. UK market estimates and forecasts, 2021 - 2033
- 6.4.2. Germany
  - 6.4.2.1. Key country dynamics
  - 6.4.2.2. Competitive scenario
  - 6.4.2.3. Regulatory framework
  - 6.4.2.4. Reimbursement scenario
  - 6.4.2.5. Germany market estimates and forecasts, 2021 - 2033
- 6.4.3. France
  - 6.4.3.1. Key country dynamics
  - 6.4.3.2. Competitive scenario
  - 6.4.3.3. Regulatory framework
  - 6.4.3.4. Reimbursement scenario
  - 6.4.3.5. France market estimates and forecasts, 2021 - 2033
- 6.4.4. Italy
  - 6.4.4.1. Key country dynamics
  - 6.4.4.2. Competitive scenario
  - 6.4.4.3. Regulatory framework
  - 6.4.4.4. Reimbursement scenario
  - 6.4.4.5. Italy market estimates and forecasts, 2021 - 2033
- 6.4.5. Spain
  - 6.4.5.1. Key country dynamics
  - 6.4.5.2. Competitive scenario
  - 6.4.5.3. Regulatory framework
  - 6.4.5.4. Reimbursement scenario
  - 6.4.5.5. Spain market estimates and forecasts, 2021 - 2033
- 6.4.6. Denmark
  - 6.4.6.1. Key country dynamics
  - 6.4.6.2. Competitive scenario
  - 6.4.6.3. Regulatory framework
  - 6.4.6.4. Reimbursement scenario
  - 6.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
- 6.4.7. Sweden
  - 6.4.7.1. Key country dynamics
  - 6.4.7.2. Competitive scenario
  - 6.4.7.3. Regulatory framework
  - 6.4.7.4. Reimbursement scenario
  - 6.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
- 6.4.8. Norway
  - 6.4.8.1. Key country dynamics
  - 6.4.8.2. Competitive scenario
  - 6.4.8.3. Regulatory framework
  - 6.4.8.4. Reimbursement scenario
  - 6.4.8.5. Norway market estimates and forecasts, 2021 - 2033
6.5. Asia Pacific
- 6.5.1. Japan
  - 6.5.1.1. Key country dynamics
  - 6.5.1.2. Competitive scenario
  - 6.5.1.3. Regulatory framework
  - 6.5.1.4. Reimbursement scenario
  - 6.5.1.5. Japan market estimates and forecasts, 2021 - 2033
- 6.5.2. India
  - 6.5.2.1. Key country dynamics
  - 6.5.2.2. Competitive scenario
  - 6.5.2.3. Regulatory framework
  - 6.5.2.4. Reimbursement scenario
  - 6.5.2.5. India market estimates and forecasts, 2021 - 2033
- 6.5.3. China
  - 6.5.3.1. Key country dynamics
  - 6.5.3.2. Competitive scenario
  - 6.5.3.3. Regulatory framework
  - 6.5.3.4. Reimbursement scenario
  - 6.5.3.5. China market estimates and forecasts, 2021 - 2033
- 6.5.4. South Korea
  - 6.5.4.1. Key country dynamics
  - 6.5.4.2. Competitive scenario
  - 6.5.4.3. Regulatory framework
  - 6.5.4.4. Reimbursement scenario
  - 6.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
- 6.5.5. Australia
  - 6.5.5.1. Key country dynamics
  - 6.5.5.2. Competitive scenario
  - 6.5.5.3. Regulatory framework
  - 6.5.5.4. Reimbursement scenario
  - 6.5.5.5. Australia market estimates and forecasts, 2021 - 2033
- 6.5.6. Thailand
  - 6.5.6.1. Key country dynamics
  - 6.5.6.2. Competitive scenario
  - 6.5.6.3. Regulatory framework
  - 6.5.6.4. Reimbursement scenario
  - 6.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
6.6. Latin America
- 6.6.1. Brazil
  - 6.6.1.1. Key country dynamics
  - 6.6.1.2. Competitive scenario
  - 6.6.1.3. Regulatory framework
  - 6.6.1.4. Reimbursement scenario
  - 6.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
- 6.6.2. Argentina
  - 6.6.2.1. Key country dynamics
  - 6.6.2.2. Competitive scenario
  - 6.6.2.3. Regulatory framework
  - 6.6.2.4. Reimbursement scenario
  - 6.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
6.7. MEA
- 6.7.1. South Africa
  - 6.7.1.1. Key country dynamics
  - 6.7.1.2. Competitive scenario
  - 6.7.1.3. Regulatory framework
  - 6.7.1.4. Reimbursement scenario
  - 6.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
- 6.7.2. Saudi Arabia
  - 6.7.2.1. Key country dynamics
  - 6.7.2.2. Competitive scenario
  - 6.7.2.3. Regulatory framework
  - 6.7.2.4. Reimbursement scenario
  - 6.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
- 6.7.3. UAE
  - 6.7.3.1. Key country dynamics
  - 6.7.3.2. Competitive scenario
  - 6.7.3.3. Regulatory framework
  - 6.7.3.4. Reimbursement scenario
  - 6.7.3.5. UAE market estimates and forecasts, 2021 - 2033
- 6.7.4. Kuwait
  - 6.7.4.1. Key country dynamics
  - 6.7.4.2. Competitive scenario
  - 6.7.4.3. Regulatory framework
  - 6.7.4.4. Reimbursement scenario
  - 6.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
- 7.2.1. Innovators
7.3. Vendor Landscape
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key customers
- 7.3.3. Global Key company market share analysis, 2024
- 7.3.4. Dentsply Sirona
  - 7.3.4.1. Company overview
  - 7.3.4.2. Financial performance
  - 7.3.4.3. Product benchmarking
  - 7.3.4.4. Strategic initiatives
- 7.3.5. Bioteck S.p.A.
  - 7.3.5.1. Company overview
  - 7.3.5.2. Financial performance
  - 7.3.5.3. Product benchmarking
  - 7.3.5.4. Strategic initiatives
- 7.3.6. Maxigen Biotech Inc.
  - 7.3.6.1. Company overview
  - 7.3.6.2. Financial performance
  - 7.3.6.3. Product benchmarking
  - 7.3.6.4. Strategic initiatives
- 7.3.7. Institut Straumann AG
  - 7.3.7.1. Company overview
  - 7.3.7.2. Financial performance
  - 7.3.7.3. Product benchmarking
  - 7.3.7.4. Strategic initiatives
- 7.3.8. Nobel Biocare Services AG (Envista)
  - 7.3.8.1. Company overview
  - 7.3.8.2. Financial performance
  - 7.3.8.3. Product benchmarking
  - 7.3.8.4. Strategic initiatives
- 7.3.9. Geistlich Holding
  - 7.3.9.1. Company overview
  - 7.3.9.2. Financial performance
  - 7.3.9.3. Product benchmarking
  - 7.3.9.4. Strategic initiatives
- 7.3.10. ZimVie Inc.
  - 7.3.10.1. Company overview
  - 7.3.10.2. Financial performance
  - 7.3.10.3. Product benchmarking
  - 7.3.10.4. Strategic initiatives
- 7.3.11. NovaBone (Halma)
  - 7.3.11.1. Company overview
  - 7.3.11.2. Financial performance
  - 7.3.11.3. Product benchmarking
  - 7.3.11.4. Strategic initiatives
- 7.3.12. Osteogenics Biomedical (Envista)
  - 7.3.12.1. Company overview
  - 7.3.12.2. Financial performance
  - 7.3.12.3. Product benchmarking
  - 7.3.12.4. Strategic initiatives
- 7.3.13. Regenity
  - 7.3.13.1. Company overview
  - 7.3.13.2. Financial performance
  - 7.3.13.3. Product benchmarking
  - 7.3.13.4. Strategic initiatives
- 7.3.14. Medtronic
  - 7.3.14.1. Company overview
  - 7.3.14.2. Financial performance
  - 7.3.14.3. Product benchmarking
  - 7.3.14.4. Strategic initiatives
- 7.3.15. BioHorizons
  - 7.3.15.1. Company overview
  - 7.3.15.2. Financial performance
  - 7.3.15.3. Product benchmarking
  - 7.3.15.4. Strategic initiatives
- 7.3.16. REGEDENT AG
  - 7.3.16.1. Company overview
  - 7.3.16.2. Financial performance
  - 7.3.16.3. Product benchmarking
  - 7.3.16.4. Strategic initiatives
- 7.3.17. IDL Dental Technologies LTD
  - 7.3.17.1. Company overview
  - 7.3.17.2. Financial performance
  - 7.3.17.3. Product benchmarking
  - 7.3.17.4. Strategic initiatives
- 7.3.18. EUCARE PHARMACEUTICALS (P) LTD
  - 7.3.18.1. Company overview
  - 7.3.18.2. Financial performance
  - 7.3.18.3. Product benchmarking
  - 7.3.18.4. Strategic initiatives
- 7.3.19. Curasan, Inc.
  - 7.3.19.1. Company overview
  - 7.3.19.2. Financial performance
  - 7.3.19.3. Product benchmarking
  - 7.3.19.4. Strategic initiatives
- 7.3.20. TBR Dental
  - 7.3.20.1. Company overview
  - 7.3.20.2. Financial performance
  - 7.3.20.3. Product benchmarking
  - 7.3.20.4. Strategic initiatives
- 7.3.21. DentiumUSA
  - 7.3.21.1. Company overview
  - 7.3.21.2. Financial performance
  - 7.3.21.3. Product benchmarking
  - 7.3.21.4. Strategic initiatives
- 7.3.22. Tecnoss Dental Srl (Tecnoss s.r.l.)
  - 7.3.22.1. Company overview
  - 7.3.22.2. Financial performance
  - 7.3.22.3. Product benchmarking
  - 7.3.22.4. Strategic initiatives
- 7.3.23. Unicare Biomedical, Inc.
  - 7.3.23.1. Company overview
  - 7.3.23.2. Financial performance
  - 7.3.23.3. Product benchmarking
  - 7.3.23.4. Strategic initiatives
- 7.3.24. Neoss
  - 7.3.24.1. Company overview
  - 7.3.24.2. Financial performance
  - 7.3.24.3. Product benchmarking
  - 7.3.24.4. Strategic initiatives
- 7.3.25. Advanced Medical Solutions Group plc
  - 7.3.25.1. Company overview
  - 7.3.25.2. Financial performance
  - 7.3.25.3. Product benchmarking
  - 7.3.25.4. Strategic initiatives
- 7.3.26. B&B Dental Implant Company
  - 7.3.26.1. Company overview
  - 7.3.26.2. Financial performance
  - 7.3.26.3. Product benchmarking
  - 7.3.26.4. Strategic initiatives
- 7.3.27. Botiss
  - 7.3.27.1. Company overview
  - 7.3.27.2. Financial performance
  - 7.3.27.3. Product benchmarking
  - 7.3.27.4. Strategic initiatives
- 7.3.28. Septodont Holding
  - 7.3.28.1. Company overview
  - 7.3.28.2. Financial performance
  - 7.3.28.3. Product benchmarking
  - 7.3.28.4. Strategic initiatives
- 7.3.29. Implant Direct Corporation (Envista)
  - 7.3.29.1. Company overview
  - 7.3.29.2. Financial performance
  - 7.3.29.3. Product benchmarking
  - 7.3.29.4. Strategic initiatives
- 7.3.30. META BIOMED CO,. LTD
  - 7.3.30.1. Company overview
  - 7.3.30.2. Financial performance
  - 7.3.30.3. Product benchmarking
  - 7.3.30.4. Strategic initiatives
- 7.3.31. SigmaGraft Biomaterials
  - 7.3.31.1. Company overview
  - 7.3.31.2. Financial performance
  - 7.3.31.3. Product benchmarking
  - 7.3.31.4. Strategic initiatives
7.4. Heat Map Analysis/ Company Market Position Analysis
7.5. Estimated Company Market Share Analysis, 2024
7.6. List of Other Key Market Players